
Rarecells Recognized Among Top 5 Disruptive Health Technologies with the Potential to Change the World by Maynooth University’s Innovation Value Institute
New York, NY, USA and Paris, France — May 12, 2026 — Rarecells, a pioneer in liquid biopsy technologies for early cancer detection, today announced




